| Issue Type | XXXX |
|---|---|
| Country | United States |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2030-05-01 |
| Par Value | 2000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 1500.00 |
| Coupon | 2.25 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 1500.000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Biogen Inc. corporate note has a X.X % fixed rate coupon paid on a XXXX basis. It was issued on MAR 12, 2000 with an issue size of XXX million USD and matures on DEC 9, 2000 with a last coupon date of FEB 28, 2020. |
Biogen Inc., founded in 1978 and headquartered in Cambridge, Massachusetts, is a leading biotechnology company dedicated to discovering, developing, and delivering innovative therapies for neurological diseases. Its key products include treatments for multiple sclerosis, spinal muscular atrophy, and Alzheimer's disease, positioning Biogen as a significant player in the biotech sector.